NMC Health, the embattled FTSE 100 healthcare provider, suspended its shares from trading and notified the market it is under regulatory investigation, after “discrepancies” in its bank statements led to the sacking of its CEO.
The company, which operates hospitals in the United Arab Emirates, said in a statement on 27 February that the Financial Conduct Authority had agreed to its request for a “temporary” suspension of its shares “to ensure the smooth operation of the market”.
